Imugene Limited Share Price
Stocks
IMU
AU000000IMU9
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
07:10:15 19/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0830 AUD | +1.22% |
|
+1.22% | -77.26% |
| Market Cap | 40.65M 28.94M 24.82M 23.18M 21.26M 39.99M 2.77B 273M 107M 1.39B 109M 106M 4.59B | P/E 2026 * |
-0.71x | P/E 2027 * | -1.05x |
|---|---|---|---|---|---|
| Enterprise Value | 40.35M 28.72M 24.64M 23.01M 21.11M 39.69M 2.75B 271M 106M 1.38B 108M 106M 4.55B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
96.9% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.22% | ||
| 1 week | +1.22% | ||
| Current month | -2.35% | ||
| 1 month | -10.75% | ||
| 3 months | -8.79% | ||
| 6 months | -66.80% | ||
| Current year | -77.26% |
| 1 week | 0.08 |  | 0.08 |
| 1 month | 0.08 | | 0.1 |
| Current year | 0.08 | | 0.41 |
| 1 year | 0.08 | | 0.46 |
| 3 years | 0.08 | | 5.1 |
| 5 years | 0.08 | | 21.25 |
| 10 years | 0.08 | | 21.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darren Keamy
DFI | Director of Finance/CFO | - | 03/03/2025 |
John Byon
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2023 |
Ursula McCurry
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hopper
CHM | Chairman | 70 | 30/10/2012 |
Lesley Russell
BRD | Director/Board Member | 66 | 22/04/2019 |
Jakob Dupont
BRD | Director/Board Member | 61 | 06/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Free | Director | 29,411 | 0.0093% | ||
| 19/12/25 | Free | Director | 14,706 | 0.0047% | ||
| 19/12/25 | Free | Director | 29,411 | 0.0093% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.22% | +1.22% | -69.82% | -96.91% | 28.49M | |
| +2.37% | +2.30% | +3.39% | +23.26% | 48.63B | |
| -0.67% | +4.41% | +486.52% | +617.49% | 46.3B | |
| +2.51% | +5.22% | +20.89% | +92.64% | 41.97B | |
| +4.10% | +3.39% | +29.93% | +16.59% | 39.51B | |
| -0.72% | -7.79% | +17.87% | +47.98% | 31.75B | |
| +3.00% | +1.46% | +31.07% | +146.25% | 16.48B | |
| +4.34% | +1.30% | - | - | 16.34B | |
| +1.44% | +1.52% | +4.22% | +31.44% | 14B | |
| +4.11% | +2.01% | +83.04% | +44.38% | 13.33B | |
| Average | +2.17% | -0.54% | +67.46% | +102.57% | 26.83B | |
| Weighted average by Cap. | +1.96% | -0.05% | +107.12% | +155.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -56.51M -40.23M -34.51M -32.22M -29.56M -55.59M -3.85B -380M -149M -1.93B -151M -148M -6.38B | -42.79M -30.46M -26.13M -24.4M -22.38M -42.09M -2.91B -288M -113M -1.46B -114M -112M -4.83B |
| Net Debt | -300K -214K -183K -171K -157K -295K -20.41M -2.02M -790K -10.24M -802K -784K -33.85M | -1M -712K -611K -570K -523K -984K -68.04M -6.73M -2.63M -34.13M -2.67M -2.61M -113M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/08/26 | A$0.0830 | +1.22% | 535,723 |
| 18/08/26 | A$0.0820 | -1.20% | 695,453 |
| 17/08/26 | A$0.0830 | +1.22% | 635,692 |
| 14/08/26 | A$0.0820 | -1.20% | 455,173 |
| 13/08/26 | A$0.0830 | +1.22% | 1,076,783 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMU Stock
Select your edition
All financial news and data tailored to specific country editions
